Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.76 USD | -10.48% | -34.04% | -58.91% |
Mar. 21 | Dermata Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 05 | Wall Street Set to Open Lower as Monthly Jobs Data Much Stronger Than Expected | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.87M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -14M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.18
x | P/E ratio 2025 * |
-0.38
x | Employees | 8 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.15% |
1 day | -10.48% | ||
1 week | -34.04% | ||
Current month | -23.37% | ||
1 month | -21.94% | ||
3 months | -43.36% | ||
6 months | -69.96% | ||
Current year | -58.91% |
Managers | Title | Age | Since |
---|---|---|---|
Gerry Proehl
CEO | Chief Executive Officer | 65 | 14-12-07 |
David Hale
FOU | Founder | 75 | 14-12-07 |
Kyri van Hoose
DFI | Director of Finance/CFO | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Hale
FOU | Founder | 75 | 14-12-07 |
Gerry Proehl
CEO | Chief Executive Officer | 65 | 14-12-07 |
Wendell Wierenga
BRD | Director/Board Member | 76 | 16-09-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 3.76 | -10.48% | 43,784 |
24-05-17 | 4.2 | -19.23% | 58,001 |
24-05-16 | 5.2 | +5.05% | 133,707 |
24-05-15 | 4.95 | -1.67% | 8,353 |
24-05-14 | 5.034 | -11.68% | 9,750 |
Delayed Quote Nasdaq, May 20, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.91% | 1.87M | |
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- DRMA Stock